Use to evaluate estrogen status in children, cisgender males, and postmenopausal cisgender females. Most useful when low estrogen concentrations are expected, regardless of the patient’s sex assigned at birth.
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Serum separator tube, lavender (EDTA), pink (K2EDTA), or green (sodium or lithium heparin).
Separate serum or plasma from cells within 2 hours of collection. Transfer 0.5 mL serum or plasma to an ARUP Standard Transport Tube. (Min 0.3 mL)
After separation from cells: Ambient: 48 hours; Refrigerated: 1 week; Frozen: 1 month
|Estradiol by Mass Spec||
|Estrone by Mass Spec||
|Estrogens Total Calculation||
For a complete set of all established reference intervals, refer to ltd.aruplab.com/Tests/Pub/0093248.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
|Component Test Code*||Component Chart Name||LOINC|
|0093247||Estradiol by Mass Spec||35384-7|
|0093249||Estrone by Mass Spec||2258-2|
|0093251||Estrogens Total Calculation||53765-4|
- Estrone (E1) and Estradiols (E2)
- Total Estrogens